Vertex Pharmaceuticals Incorporated Forecast and Target Price logo

Vertex Pharmaceuticals Incorporated Forecast and Target Price

$464.12

Vertex Pharmaceuticals Incorporated (VRTX) Share Price Forecast

Currently 38 wall-street analysts regularly analyze the financials of Vertex Pharmaceuticals Incorporated on a frequent basis to provide recommendations along with target share price. 38 analysts offering 12-month price forecasts for Vertex Pharmaceuticals Incorporated (VRTX) have a share price target of $515.14. This median of share price forecast represents a 10.99% upside from the latest price of $464.12 as on 13.12.24.

Vertex Pharmaceuticals Incorporated (VRTX) Price vs Consensus Price Target

Price
Target Price
As per the chart shown above, analysts believe that the Vertex Pharmaceuticals Incorporated (VRTX) share price will touch around $515.14 in next 12-months.

Vertex Pharmaceuticals Incorporated (VRTX) Share Price Forecast v/s Share Price Today

Below is a chart showing the percentage difference between Vertex Pharmaceuticals Incorporated's share price and its median forecast price. As on 13.12.24, the difference is -8.49%

Vertex Pharmaceuticals Incorporated (VRTX): Difference between Current Price & Median Forecasted Price

Difference in Percentage terms

Vertex Pharmaceuticals Incorporated (VRTX) Share Price : Analyst Recommendation

Based on 38 analysts tracking and researching Vertex Pharmaceuticals Incorporated (VRTX) share have buy recommendation on an average.
3M Ago1M AgoCurrent
Buy
16
16
16
Outperform
10
10
10
Hold
8
10
10
Underperform
1
1
1
Sell
1
1
1

Vertex Pharmaceuticals Incorporated (VRTX) Share Price Technical Analysis

50 Day Moving Average v/s Current Share Price

Moving Average
Price

200 Day Moving Average v/s Current Share Price

Moving Average
Price